WO2001032643A1 - Method for the preparation of 5-carboxyphthalide - Google Patents

Method for the preparation of 5-carboxyphthalide Download PDF

Info

Publication number
WO2001032643A1
WO2001032643A1 PCT/DK2000/000606 DK0000606W WO0132643A1 WO 2001032643 A1 WO2001032643 A1 WO 2001032643A1 DK 0000606 W DK0000606 W DK 0000606W WO 0132643 A1 WO0132643 A1 WO 0132643A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
carboxyphthalide
reaction
trioxane
terephthalic acid
Prior art date
Application number
PCT/DK2000/000606
Other languages
French (fr)
Inventor
Hans Petersen
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Priority to AU11309/01A priority Critical patent/AU1130901A/en
Publication of WO2001032643A1 publication Critical patent/WO2001032643A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3

Definitions

  • the present invention relates to a novel process for the preparation of 5-carboxyphthalide, a starting material for the manufacture of the well-known anti depressant drug citalopram, l-[3- (dimethylamino)propyl]-l -(4-fluorophenyl)-l ,3-dihydro-5-isobenzofurancarbonitrile.
  • Citalopram is a selective serotonin reuptake inhibitor which has successfully been marketed as an antidepressant drug for some years. It has the following structure:
  • Formula I and it may be prepared by the process described in US Patent No 4,650,884 according to which 5-cyanophthalide is subjected to two successive Grignard reactions, i.e. with 4-fluoro- phenyl magnesium halogenide and N,N-dimethylaminopropyl magnesium halogenide, respectively, and the resulting dicarbinol compound is subjected to a ring closure reaction by dehydration.
  • the 5-cyanophthalide may in its turn be obtained by reaction of 5- carboxyphthalide with a dehydrating agent and a sulfonamide of the formula H 2 N-SO,-R wherein R is NH 2 , alkyloxy, optionally substituted phenyloxy, or substituted phenyl in order to obtain 5-cyanophthalide, cf. our co-pending Danish patent application No. PA199801718.
  • 5-Carboxyphthalide has been described as a useful intermediate in the polymer and paint industry. However, no reliable commercial source is available at present.
  • a known process comprises catalytic hydrogenation of trimellithic acid (DE-A1 2630927). This process provides a mixture of the 5- and 6-carboxyphthalides and, accordingly, it requires elaborate and costly purification.
  • 5- carboxyphthalide is synthesised by reaction of terephthalic acid with trioxane in liquid SO 3 . During this process, trioxane sublimates and precipitates thereby obstructing the equipment.
  • 5-carboxyphthalide may be prepared from terephthalic acid in high yields by a convenient, cost-effective procedure. Description of the invention
  • the present invention provides a process for the manufacture of 5- carboxyphthalide
  • the Lewis acid may be any suitable Lewis acid.
  • suitable Lewis acids are ZnCl 2 , PC1 5 , SnCL,, TiCl 4 , etc.
  • a mineral acid is used. Any suitable mineral acid such as poly-phosphoric acid may be used.
  • the terephthalic acid is condensed with trioxan or paraformaldehyde liberating water that reacts with the acid present.
  • 5-carboxyphthalide may be isolated as follows: The reaction mixture is hydrolysed with water. The condensed product, 5-carboxyphthalide inclusive possible diphthalide impurities may then be filtered off, and the 5-carboxyphthalide may be dissolved in aqueous medium by adjusting pH to about 6.7 to 7.3, leaving possible diphthalide impurities in the solid phase. The diphthalide present may be filtered off whereupon 5-carboxyphthalide may be precipitated by acidification, washed with water and dried.
  • 1.0-1.33 equivalents CH 2 O and 1.0-2.5, preferably 1.0-2 equivalents acid are used per equivalent terephthalic acid. Also lower amount of acid such as 0.1 to 1.0 equivalents may possibly be used.
  • reaction is carried out in a suitable solvent such as nitrobenzene trifluoromethyl benzene, methylcyclohexane.
  • a suitable solvent such as nitrobenzene trifluoromethyl benzene, methylcyclohexane.
  • the reaction of terephthalic acid with trioxane or paraformaldehyde is carried out at elevated temperature, at about 50-155 °C, preferably 135-145°C, most preferably at about 140°C.
  • the reaction time is not critical and may easily be determined by a person skilled in the art.
  • the adjustment of pH to 6.3 to 7.3 in order to dissolve the 5-carboxyphthalide formed may be effected by NaOH.
  • the terephthalic acid used as a starting material is commercially available.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)

Abstract

By a method comprising reaction of terephthalic acid (formula (II)) with trioxane or paraformaldehyde in the presence of a Lewis acid or a mineral acid, 5-carboxyphthalide is obtained with very high purity and in high yields at mild reaction conditions.

Description

METHOD FOR THE PREPARATION OF 5-CARBOXYPHTHALIDE
The present invention relates to a novel process for the preparation of 5-carboxyphthalide, a starting material for the manufacture of the well-known anti depressant drug citalopram, l-[3- (dimethylamino)propyl]-l -(4-fluorophenyl)-l ,3-dihydro-5-isobenzofurancarbonitrile.
Background of the Invention.
Citalopram is a selective serotonin reuptake inhibitor which has successfully been marketed as an antidepressant drug for some years. It has the following structure:
Figure imgf000002_0001
Formula I and it may be prepared by the process described in US Patent No 4,650,884 according to which 5-cyanophthalide is subjected to two successive Grignard reactions, i.e. with 4-fluoro- phenyl magnesium halogenide and N,N-dimethylaminopropyl magnesium halogenide, respectively, and the resulting dicarbinol compound is subjected to a ring closure reaction by dehydration. The 5-cyanophthalide may in its turn be obtained by reaction of 5- carboxyphthalide with a dehydrating agent and a sulfonamide of the formula H2N-SO,-R wherein R is NH2, alkyloxy, optionally substituted phenyloxy, or substituted phenyl in order to obtain 5-cyanophthalide, cf. our co-pending Danish patent application No. PA199801718.
5-Carboxyphthalide has been described as a useful intermediate in the polymer and paint industry. However, no reliable commercial source is available at present. A known process comprises catalytic hydrogenation of trimellithic acid (DE-A1 2630927). This process provides a mixture of the 5- and 6-carboxyphthalides and, accordingly, it requires elaborate and costly purification. According to J. Org. Chem. 1970, 35, p. 1695-1696, 5- carboxyphthalide is synthesised by reaction of terephthalic acid with trioxane in liquid SO3. During this process, trioxane sublimates and precipitates thereby obstructing the equipment.
Though a number of other methods failed, it has now been found that 5-carboxyphthalide may be prepared from terephthalic acid in high yields by a convenient, cost-effective procedure. Description of the invention
Accordingly, the present invention provides a process for the manufacture of 5- carboxyphthalide
Figure imgf000003_0001
comprising reaction of terephthalic acid
Figure imgf000003_0002
with trioxane or paraformaldehyde
Figure imgf000003_0003
in the presence of a Lewis acid or a mineral acid.
The Lewis acid may be any suitable Lewis acid. Examples of suitable Lewis acids are ZnCl2, PC15, SnCL,, TiCl4, etc. Alternatively, a mineral acid is used. Any suitable mineral acid such as poly-phosphoric acid may be used.
By the process of the invention, 5-cyanophthalide is obtained with very high purity and in high yields. Furthermore, as compared with the prior art process (J. Org. Chem. 1970, 35, p. 1695-1696), the process of the invention takes place at much milder reaction conditions without precipitation of sublimated trioxane which obstructs the equipment e.g. by precipitating in condensers. Thus, the reaction in liquid SO3 according to J. Org. Chem. 1970, 35, p. 1695-1696 requires very expensive equipment and is very unpleasant to handle.
In the method of the invention, the terephthalic acid is condensed with trioxan or paraformaldehyde liberating water that reacts with the acid present. When the reaction is complete, 5-carboxyphthalide may be isolated as follows: The reaction mixture is hydrolysed with water. The condensed product, 5-carboxyphthalide inclusive possible diphthalide impurities may then be filtered off, and the 5-carboxyphthalide may be dissolved in aqueous medium by adjusting pH to about 6.7 to 7.3, leaving possible diphthalide impurities in the solid phase. The diphthalide present may be filtered off whereupon 5-carboxyphthalide may be precipitated by acidification, washed with water and dried.
Preferably 1.0-1.33 equivalents CH2O and 1.0-2.5, preferably 1.0-2 equivalents acid are used per equivalent terephthalic acid. Also lower amount of acid such as 0.1 to 1.0 equivalents may possibly be used.
The reaction is carried out in a suitable solvent such as nitrobenzene trifluoromethyl benzene, methylcyclohexane. A person skilled in the art may easily determine suitable solvents.
The reaction of terephthalic acid with trioxane or paraformaldehyde is carried out at elevated temperature, at about 50-155 °C, preferably 135-145°C, most preferably at about 140°C. The reaction time is not critical and may easily be determined by a person skilled in the art.
The adjustment of pH to 6.3 to 7.3 in order to dissolve the 5-carboxyphthalide formed may be effected by NaOH.
Acidification in order to precipitate the 5-carboxyphthalide may be carried out by adding sulphuric acid or a mineral acid until pH = 2.
The terephthalic acid used as a starting material is commercially available.
Examples The invention is further illustrated by the following example.
Example 1 5-CarboxyphthaIid
Terephthalic acid (10 kg) is charged into a reactor. ZnCl2 (2 equivalents in nitrobenzene) is added and then paraformaldehyde (1.33 equivalents, 0.24 kg/kg terephthalic acid) is added.
The mixture is agitated at 125 °C for 17 hours. Water (13 kg/kg terephthalic acid and filter aid is added, the temperature is adjusted to about 70 °C. The precipitate is filtered of, washed with water and suspended in water. The pH of the suspension is adjusted to about 7 with NaOH, activated carbon, 0.07 kg/kg is added, and then the mixture is filtered, the precipitate is rinsed with water. The temperature of the filtrate is adjusted to about 65°C and the pH is adjusted to about 2 with 50% sulfuric acid. The 5-carboxyphthalide precipitated is separated by filtration washed and dried. Yield 83%.

Claims

1. A method for the preparation of 5-carboxyphthalide
Figure imgf000005_0001
comprising reaction of terephthalic acid
Figure imgf000005_0002
with trioxane or paraformaldehyde
,o.
o o
HO(CH2)nH or ^^ in the presence of a Lewis acid or a mineral acid.
2. The method of Claim 1 wherein trioxane is used as reactant.
3. The method of Claim 1 wherein para- formaldehyde is used as reactant.
4. The method of Claims 2 or 3, wherein the acid is a Lewis acid, such as ZnCl2, PC15, SnCl4 or TiCl4.
5. The method of Claim 2 or 3 wherein the acid is a mineral acid, such as a poly- phosphoric acid.
6. The method of any of Claim 1 to 5 wherein 1.0-1.33 equivalents CH2O and 1.0-2.5, preferably 1.0-2 equivalents acid are used per equivalent terephthalic acid.
7. The method of any of Claim 1 to 5 wherein the reaction of terephthalic acid with trioxane or paraformaldehyde is carried out at elevated temperature, e.g. at about 50-145 °C, preferably 115-125°C, most preferably at about 120°C.
PCT/DK2000/000606 1999-11-01 2000-11-01 Method for the preparation of 5-carboxyphthalide WO2001032643A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU11309/01A AU1130901A (en) 1999-11-01 2000-11-01 Method for the preparation of 5-carboxyphthalide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901568 1999-11-01
DKPA199901568 1999-11-01

Publications (1)

Publication Number Publication Date
WO2001032643A1 true WO2001032643A1 (en) 2001-05-10

Family

ID=8106144

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2000/000606 WO2001032643A1 (en) 1999-11-01 2000-11-01 Method for the preparation of 5-carboxyphthalide

Country Status (2)

Country Link
AU (1) AU1130901A (en)
WO (1) WO2001032643A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458973B1 (en) 2000-01-18 2002-10-01 Norpharma S.P.A. Process for the preparation of 5-carboxyphthalide
US6888009B2 (en) 1999-11-01 2005-05-03 H. Lundbeck A/S Method for the preparation of 5-carboxyphthalide
US7002025B2 (en) 2000-03-07 2006-02-21 Resolution Chemicals Limited Process for the preparation of citalopram
WO2006090409A1 (en) * 2005-02-28 2006-08-31 Kekule Pharma Ltd., An improved process for the preparation of 5 - carboxyphthalide
CN112062741A (en) * 2019-06-11 2020-12-11 太仓市茜泾化工有限公司 Preparation method of 5-carboxylic acid phthalide

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3607884A (en) * 1969-03-11 1971-09-21 Mobil Oil Corp Preparation of 5-carboxyphthalide in liquid sodium trioxide
DE2242007A1 (en) * 1972-08-26 1974-03-14 Basf Ag Phthalimidine and polyphthalimidine prepn - from diphthalides or mono-phthalide carboxylic acids and mono- or polyisocyanates reacted esp. in polar solvents
DE2630927A1 (en) * 1976-07-09 1978-01-19 Basf Ag METHOD FOR PRODUCING PHTHALIDOCARBONIC ACID- (5)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3607884A (en) * 1969-03-11 1971-09-21 Mobil Oil Corp Preparation of 5-carboxyphthalide in liquid sodium trioxide
DE2242007A1 (en) * 1972-08-26 1974-03-14 Basf Ag Phthalimidine and polyphthalimidine prepn - from diphthalides or mono-phthalide carboxylic acids and mono- or polyisocyanates reacted esp. in polar solvents
DE2630927A1 (en) * 1976-07-09 1978-01-19 Basf Ag METHOD FOR PRODUCING PHTHALIDOCARBONIC ACID- (5)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LEROY S. FORNEY ET AL.: "The reaction of formaldehyde with deactivated benzoic acids. An ester-directed electrophilic aromatic substitution process", J. ORG. CHEM., vol. 36, no. 5, 1971, pages 689 - 693, XP002936414 *
LEROY S. FORNEY: "Reaction of terephthalic acid with formaldehyde in sulfur trioxide media", JOURNAL OF ORGANIC CHEMISTRY, vol. 35, no. 5, May 1970 (1970-05-01), pages 1695 - 1696, XP002936415 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6888009B2 (en) 1999-11-01 2005-05-03 H. Lundbeck A/S Method for the preparation of 5-carboxyphthalide
US6458973B1 (en) 2000-01-18 2002-10-01 Norpharma S.P.A. Process for the preparation of 5-carboxyphthalide
US6703516B2 (en) 2000-01-18 2004-03-09 Infosint Sa Process for the preparation of 5-carboxyphthalide
US7002025B2 (en) 2000-03-07 2006-02-21 Resolution Chemicals Limited Process for the preparation of citalopram
WO2006090409A1 (en) * 2005-02-28 2006-08-31 Kekule Pharma Ltd., An improved process for the preparation of 5 - carboxyphthalide
CN112062741A (en) * 2019-06-11 2020-12-11 太仓市茜泾化工有限公司 Preparation method of 5-carboxylic acid phthalide

Also Published As

Publication number Publication date
AU1130901A (en) 2001-05-14

Similar Documents

Publication Publication Date Title
US6403813B1 (en) Method for the preparation of 5-carboxyphthalide
AU764161B2 (en) Method for the preparation of 5-cyanophthalide
WO2001032643A1 (en) Method for the preparation of 5-carboxyphthalide
NL8201307A (en) NEW PROCESS FOR THE PREPARATION OF D-2- (6-METHOXY-2-NAFTYL) PROPIONIC ACID.
CN111039845A (en) Preparation method of 4-fluoro-7-bromoisatin
JPH04217970A (en) New method of synthesis of 5-acyloxy and 5-alkoxy-
US7687645B2 (en) Intermediates for the preparation of citalopram and escitalopram
JPS62135B2 (en)
JP2018108978A (en) Method for producing intermediate of biotin, and method for producing biotin
JPS62242644A (en) Method for oxidizing alkylphenol or such
RU2058297C1 (en) Method for production of 2-(4-ethyl benzoyl)benzoic acid
JP4085199B2 (en) Method for producing O, O-dimethyl-O- (p-cyanophenyl) phosphorothioate
JPH01160969A (en) Separation of 2-substituted-imidazole
JPH045252A (en) Production of 4,4'-dihydroxy-3,3',5,5'-tetramethyl-diphenylmethane
JPH0341067A (en) Production of 2-(4-hydroxyphenyl)-2-(4'-maleimidephenyl) propane
RU1750166C (en) Method of synthesis of methylene-bis-anthranilic acid
JP4428730B2 (en) Method for producing 2,5-dihydrofuran
JP4827364B2 (en) Method for purifying p-cyanophenol
CN114853684A (en) Purification method of Lomepilon intermediate
TWI252848B (en) Process for the preparation of 5-formylphthalide
WO2004089924A1 (en) Process for the preparation of 5-bromophthalide
JPS62480A (en) Production of phthalide
JPH093059A (en) Production of alpha-methyl-2-thiopheneacetic acid derivative
WO2004096750A1 (en) Process for producing 3-nitro-4-alkoxybenzoic acid
JPH0558422B2 (en)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase